Facebook Linkedin Twitter
Inside Precision Medicine Study: Cancer Screening Costs $43B Annually in U.S.

Health care costs

Cancer Screening Illustration
News & Features

Study: Cancer Screening Costs $43B Annually in U.S.

0
Digital Brain hovering above a series of computer chips to illustrate artificial intelligence (AI)-powered tools to help clinicians make better treatment choices based on patient tests
Informatics

AI Tool Can Predict Hospitalized Patients at Risk of Deterioration

0
Close up of melanoma
News & Features

Delayed Melanoma Diagnoses from COVID-19 Lockdown Cost £6 Billion in Europe

0
Overweight teen, cardiometabolic risk
Informatics

Study to Leverage Machine Learning Models to Assess Cardiometabolic Risks in Adolescents and Young Adults

0
Colorful rare disease awareness ribbon with a group of different colored sillouettes symbolizing people with rare diseases.
Molecular Dx

Early Rare Disease Diagnosis Could Save as Much as $500,000 per Patient

0
Cancer care
News & Features

AACR Cancer Progress Report Touts Advances, Advocates Continued Government Research Funding

0
Mountain Sunset
News & Features

Tackling Rare Disease in India

0
Young woman on beach with sunburn, rear view
News & Features

Histone Deacetylation Inhibitor Shows Promise for Treating Basal Cell Carcinoma

0
$100 Genome
Molecular Dx

$100 Genome Announced by MGI at AGBT Conference

Julianna LeMieux, PhD
0
GNS and Swedish Cancer Institute launch collaboration aimed at advancing the use of precision medicine in care for breast cancer patients. [Source: © Arto/Fotolia.com]
Molecular Dx

Oncotype DX Prognostic Breast Cancer Test Can Lower Care Costs

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine